Evidence map›Paper›PMID 22431561›Full record

ArticleAmerican journal of epidemiology2012

Derivation and validation of the Denver Human Immunodeficiency Virus (HIV) risk score for targeted HIV screening.

Jason S Haukoos, Michael S Lyons, Christopher J Lindsell, Emily Hopkins, Brooke Bender, Richard E Rothman, Yu-Hsiang Hsieh, Lynsay A Maclaren, Mark W Thrun, Comilla Sasson and 1 more

Registry-linked trialAbstract readValidation Study
In one paragraph

Article in American journal of epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02959684 (Strategic Screening for Infectious Diseases), which is not on this map. Cited by 51 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02959684 unknown statusnot on this mapstarted 2017, after this paper: background citation

Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France

TypeobservationalSponsorUniversity Paris 7 - Denis DiderotRan2017 to 2019Enrolled70,000ConditionsHIV, Hepatitis C, Hepatitis B, Tuberculosis
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Randomized comparison of universal and targeted HIV screening in the emergency department.Journal of acquired immune deficiency syndromes (1999) · 2013
    Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Developing HIV risk prediction tools in four African settings.Tropical medicine & international health : TM & IH · 2023
    Article
  16. Article
  17. Article
  18. Prediction Model for the Risk of HIV Infection among MSM in China: Validation and Stability.International journal of environmental research and public health · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jason S HaukoosDepartment of Emergency Medicine, Denver Health Medical Center, 777 Bannock Street, Mail Code 0108, Denver, CO 80204, USA. jason.haukoos@dhha.org
Michael S Lyons
Christopher J Lindsell
Emily Hopkins
Brooke Bender
Richard E Rothman
Yu-Hsiang Hsieh
Lynsay A Maclaren
Mark W Thrun
Comilla Sasson
Richard L Byyny

Funding

Strategies to Identify Undiagnosed HIV Infection in the Emergency DepartmentK02HS017526 · AHRQ · DENVER HEALTH AND HOSPITAL AUTHORITY · PI HAUKOOS, JASON · 2008 to 2012
$554k
AHRQ HHS K02 HS017526AHRQ HHS K02HS017526
6 · The paper itself

Abstract

Targeted screening remains an important approach to human immunodeficiency virus (HIV) testing. The authors aimed to derive and validate an instrument to accurately identify patients at risk for HIV infection, using patient data from a metropolitan sexually transmitted disease clinic in Denver, Colorado (1996-2008). With multivariable logistic regression, they developed a risk score from 48 candidate variables using newly identified HIV infection as the outcome. Validation was performed using an independent population from an urban emergency department in Cincinnati, Ohio. The derivation sample included 92,635 patients; 504 (0.54%) were diagnosed with HIV infection. The validation sample included 22,983 patients; 168 (0.73%) were diagnosed with HIV infection. The final score included age, gender, race/ethnicity, sex with a male, vaginal intercourse, receptive anal intercourse, injection drug use, and past HIV testing, and values ranged from -14 to +81. For persons with scores of <20, 20-29, 30-39, 40-49, and ≥50, HIV prevalences were 0.31% (95% confidence interval (CI): 0.20, 0.45) (n = 27/8,782), 0.41% (95% CI: 0.29, 0.57) (n = 36/8,677), 0.99% (95% CI: 0.63, 1.47) (n = 24/2,431), 1.59% (95% CI: 1.02, 2.36) (n = 24/1,505), and 3.59% (95% CI: 2.73, 4.63) (n = 57/1,588), respectively. The risk score accurately categorizes patients into groups with increasing probabilities of HIV infection.

Indexed as

Decision Support TechniquesAdolescentAdultAgedAged, 80 and overFemaleHealth Status IndicatorsHIV InfectionsHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisProspective StudiesRisk AssessmentRisk Factors

Identifiers

PMID22431561
PMCPMC3390011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.